298
Views
14
CrossRef citations to date
0
Altmetric
Research Articles

International normalized ratio stabilization in newly initiated warfarin patients with nonvalvular atrial fibrillation

, , , , , & show all
Pages 2437-2442 | Accepted 19 Aug 2014, Published online: 02 Sep 2014

References

  • Goldstein LB, Bushnell CD, Adams RJ, et al. American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Epidemiology and Prevention, Council for High Blood Pressure Research, Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research. Guidelines for the primary prevention of stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2011;42:517-84. Erratum in: Stroke 2011;42:e26
  • Heneghan C, Tyndel S, Bankhead C, et al. Optimal loading dose for the initiation of warfarin: a systematic review. BMC Cardiovasc Disord 2010;10:18
  • Mahtani KR, Heneghan CJ, Nunan D, et al. Optimal loading dose of warfarin for the initiation of oral anticoagulation. Cochrane Database Syst Rev 2012;12:CD008685
  • Nutescu E, Chuatrisorn I, Hellenbart E. Drug and dietary interactions of warfarin and novel oral anticoagulants: an update. J Thromb Thrombolysis 2011;31:326-43
  • Witt DM, Delate T, Clark NP, et al.; Warfarin Associated Research Projects and other EnDeavors (WARPED) Consortium. Outcomes and predictors of very stable INR control during chronic anticoagulation therapy. Blood 2009;114:952-6
  • Rombouts EK, Rosendaal FR, van der Meer FJ. Subtherapeutic oral anticoagulant therapy: frequency and risk factors. Thromb Haemost 2009;101:552-6
  • Rosendaal FR, Cannegieter SC, van der Meer FJ, et al. A method to determine the optimal intensity of oral anticoagulant therapy. Thromb Haemost 1993;69:236-9
  • Nelson WW, Choi JC, Vanderpoel J. Impact of comorbidities and patient characteristic on international normalized ratio control over time in patients with nonvalvular atrial fibrillation. Am J Cardiol 2013;112:509-12

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.